CHCHD2 and Parkinson's disease

Affiliations

• ¹ Department of Clinical Genetics, VU University Medical Center, Amsterdam, Netherlands; German Center for Neurodegenerative diseases, Tübingen, Germany.
• ² Department of Molecular Neurosciences, Institute of Neurology, University College London, London, UK.
• ³ Sorbonne Université, Université Pierre et Marie Curie-Paris 06, Inserm, Centre National de la Reserche Scientifique, and Institute du Cerveau et de la Moelle épinière, Paris, France; Assistance Publique Hôpitaux de Paris, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France.
• ⁴ German Center for Neurodegenerative diseases, Tübingen, Germany; Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
• ⁵ Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD, USA.
• ⁶ National Hospital for Neurology and Neurosurgery, University College London, London, UK.
• ⁷ Rita Lila Weston Institute, University College London, London, UK.
• ⁸ Department of Clinical Genetics, VU University Medical Center, Amsterdam, Netherlands; German Center for Neurodegenerative diseases, Tübingen, Germany; Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.
• ⁹ Department of Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; Centre for Genetic Epidemiology, Institute for Clinical Epidemiology and Applied Biometry, University of Tübingen, Tübingen, Silcherstraße 5, 70276, Germany. Electronic address: manu.sharma@uni-tuebingen.de.